1
Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
Condition(s):Melanoma; Metastatic MelanomaLast Updated:October 24, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Melanoma; Metastatic MelanomaLast Updated:October 24, 2017Terminated
Condition(s):Advanced or Inoperable Malignant Melanoma With BRAF MutationLast Updated:September 4, 2014Suspended
Condition(s):Cancer; Cancer, Treatment-RelatedLast Updated:April 7, 2022Completed
Condition(s):Acral Lentiginous Melanoma; Mucosal MelanomaLast Updated:January 10, 2020Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.